PROVIDER REVIEW
Mochi Health GLP-1 Review: Obesity Medicine Focus
Mochi Health is a telehealth platform that positions its GLP-1 program around board-certified obesity medicine physicians rather than general practitioners or nurse practitioners. This review covers Mochi's prescription process, the clinician model, medications offered, pricing, and what distinguishes its approach from other telehealth GLP-1 providers.
Affiliate disclosure: We may earn a referral fee if you complete a consultation through a partner link on this site. Program details, pricing, and medication availability change — verify current information directly with Mochi Health before enrolling. This is not medical advice.
About Mochi Health
Mochi Health is a telehealth platform that focuses specifically on weight management and positions its clinical model around board-certified obesity medicine physicians. Board certification in obesity medicine (through the American Board of Obesity Medicine, or ABOM) represents a physician who has completed additional training and examination in the medical treatment of obesity as a chronic disease.
This positions Mochi differently from platforms that use general practitioners or advanced practice providers (nurse practitioners, physician assistants) as the primary prescribers. Obesity medicine specialists typically have deeper expertise in the nuances of GLP-1 dosing, managing side effects, evaluating complex comorbidities, and approaching obesity as a chronic condition rather than a lifestyle issue.
Mochi operates as a licensed telehealth service. All prescribing decisions are made by licensed clinicians. No prescription is guaranteed before evaluation.
Clinician Model: Obesity Medicine Physicians
The primary differentiator Mochi Health emphasizes is that patients are evaluated and managed by board-certified obesity medicine physicians rather than by general providers. Key implications:
- Specialized expertise: Obesity medicine-trained physicians are specifically trained in pharmacologic treatment of obesity, including GLP-1 receptor agonists, their mechanisms, titration, and management of complex cases
- Chronic disease approach: Obesity medicine recognizes obesity as a chronic, relapsing condition — which shapes how these clinicians approach long-term medication management versus a short-term intervention mindset
- Complex comorbidity management: Patients with multiple weight-related conditions (diabetes, hypertension, sleep apnea, PCOS, etc.) may benefit from a specialist's evaluation of how GLP-1 therapy interacts with their full clinical picture
- Synchronous visits: Mochi typically uses scheduled video consultations rather than asynchronous text-based intake — patients speak directly with a physician
Verify Mochi's current clinical staffing model directly — program structures can evolve over time.
Prescription Process
Mochi Health's prescription process reflects its physician-led model:
- Initial intake: You complete an online health questionnaire covering your medical history, current medications, weight history, comorbidities, and treatment goals.
- Scheduled video consultation: You are matched with a board-certified obesity medicine physician for a video visit. The physician reviews your history, asks follow-up questions, and performs a thorough clinical evaluation — this is a real clinical encounter, not just an asynchronous form review.
- Prescribing decision: The physician determines whether a GLP-1 medication is clinically appropriate, and if so, which medication and starting dose. If not appropriate, the physician advises on alternative approaches. No prescription is guaranteed.
- Pharmacy fulfillment: If prescribed, medication is dispensed from a licensed pharmacy and delivered to your home.
- Ongoing care: Follow-up visits and ongoing physician access are part of the program for dose management and continued clinical evaluation.
Medications Available Through Mochi Health
Mochi Health has offered both brand-name FDA-approved GLP-1 medications and compounded GLP-1 preparations, depending on clinical eligibility and availability. The specific medications available vary — verify current options directly with Mochi before enrolling.
- Brand-name options: FDA-approved GLP-1 and GIP/GLP-1 medications for weight management (Wegovy, Zepbound) or diabetes (Ozempic, Mounjaro), depending on clinical indication
- Compounded options: Mochi has offered compounded semaglutide or tirzepatide preparations for eligible patients. These are not FDA-approved products and are not generic equivalents. See our compounded GLP-1 guide for full context.
Given Mochi's obesity medicine specialist model, patients may receive more detailed discussion of medication options, risks, and benefits than from generalist telehealth platforms.
Pricing Structure
Mochi Health's pricing reflects a physician-led model and typically includes:
- An initial consultation fee or monthly membership covering physician access, visits, and ongoing care
- Medication cost, separate from the program fee — brand-name products may be insured; compounded options are typically self-pay
- Follow-up visit fees or ongoing monthly subscription (structure varies — confirm directly)
- Potential lab work costs if required
Mochi's program fee may be higher than some generalist telehealth platforms due to its physician specialist model. Whether that premium is worth it depends on your individual clinical needs and preferences. Always verify total costs directly with Mochi before enrolling.
Who Mochi Health May Be For
Mochi Health may be a strong fit for patients who:
- Have complex medical histories, multiple comorbidities, or prior unsuccessful GLP-1 treatment
- Want to work with a physician who specializes in obesity medicine rather than a general provider
- Value synchronous video visits with a physician over asynchronous text-based evaluations
- Are looking for a more clinical, medically-focused approach than a behavioral app plus prescription model
- Have questions about GLP-1 medication selection, dosing strategy, or interaction with other conditions that warrant specialist input
Mochi may be less suited for patients who simply want the fastest or lowest-cost path to a prescription, or who have straightforward eligibility and prefer a simpler self-service telehealth experience.
Considerations Before Enrolling
- Clinician credentials: Confirm that your assigned clinician is board-certified in obesity medicine (ABOM) — and understand what happens if your primary physician is unavailable for follow-up.
- Medication options: Ask which medications are currently available, whether any are compounded, which pharmacy is used, and the compounding pharmacy's accreditation status.
- Total cost: Understand the full cost including initial consultation, monthly fee, medication, and labs. Ask about cost if your dose changes or you need additional visits.
- Insurance: Ask whether Mochi assists with insurance prior authorization for brand-name medications and whether you can use insurance to offset medication costs.
- Cancellation: Understand the cancellation process and whether unused subscription time is refundable.
Frequently Asked Questions
Board certification in obesity medicine (ABOM) means a physician has completed additional education and passed a standardized examination focused on the medical treatment of obesity. These physicians have training beyond a general MD or DO in areas like pharmacologic treatment of obesity, behavioral approaches, bariatric medicine, and treating obesity as a chronic disease. This is distinct from a general practitioner or nurse practitioner who may also prescribe GLP-1 medications but without this specialized certification.
No. Mochi Health, like all legitimate telehealth providers, requires a full clinical evaluation before any prescription is issued. The physician conducts a thorough evaluation and prescribes only when clinically appropriate. No prescription is guaranteed before your consultation is complete.
Mochi's program fees may be higher than some generalist telehealth platforms given its physician specialist model and synchronous visit structure. Whether the additional cost is warranted depends on your individual clinical situation. Patients with complex histories or multiple comorbidities may find the specialist access more valuable than the cost difference. Always verify current pricing directly with Mochi.
Mochi Health has offered both brand-name FDA-approved GLP-1 medications and compounded preparations. The specific medications available at any given time depend on clinical eligibility, state regulations, and formulary. Verify current medication options directly with Mochi — availability changes and should not be assumed from third-party sources including this page.
COMPARE ALL PROGRAMS
See How Mochi Health Compares
Our full comparison guide covers licensed telehealth GLP-1 programs side by side — clinician model, prescription process, medication options, cost structure, and program approach.
We may earn a referral fee if you complete a consultation through a partner link. This is not medical advice. Talk with a licensed clinician.